Multiple Myeloma | Toxic Exposure

Multiple myeloma, a devastating form of blood cancer that affects plasma cells in bone marrow, has increasingly been linked to toxic chemical exposures in occupational and environmental settings. This aggressive cancer carries a grim prognosis, with most patients facing a median survival rate of five to seven years despite advances in treatment. For victims and families confronting this diagnosis, understanding the connection between toxic exposure and multiple myeloma can be crucial for securing compensation and holding responsible parties accountable.

Understanding Multiple Myeloma and Its Toxic Triggers

Multiple myeloma develops when plasma cells, which normally produce infection-fighting antibodies, become malignant and multiply uncontrollably. These cancerous cells accumulate in bone marrow, interfering with normal blood cell production and weakening bones throughout the body. Patients typically experience bone pain, frequent infections, anemia, and kidney problems as the disease progresses.

Scientific research has established compelling links between multiple myeloma and exposure to various toxic substances. Benzene, a petroleum-based chemical found in gasoline, solvents, and industrial processes, represents one of the most documented risk factors. Workers in refineries, chemical manufacturing plants, and automotive repair facilities face elevated exposure risks through inhalation and skin contact.

Agricultural workers encounter multiple myeloma risks through pesticide and herbicide exposure, particularly chemicals containing organophosphates and carbamates. Studies have identified increased cancer rates among farmers, crop dusters, and pesticide applicators who experience chronic exposure to these substances without adequate protection.

Military personnel and veterans face unique exposure risks from diesel exhaust, jet fuels, and various chemicals used in military operations. Camp Lejeune water contamination, which affected thousands of service members and families between 1953 and 1987, included multiple carcinogens now linked to blood cancers including multiple myeloma.

This type of cancer forms in a plasma cell, a type of white blood cell that helps you fight infections by making antibodies that recognize and attack germs. The condition causes cancer cells to accumulate in the bone marrow, crowding out healthy blood cells. The cancer cells produce abnormal proteins that may cause complications.

Cancer cases have been linked to exposure to benzene, glyphosate, solvents, diesel exhaust and several other industrial toxins that workers may deal with for weeks or years at a time. Cancer-causing agents have been identified, but employers have still failed to protect workers from the risks of toxic exposure.

Treatment for multiple myeloma isn’t always necessary though is available for people with complications. Complications include:

• Infections
• Bone problems—bone pain, thinning bones and broken bones.
• Reduced kidney function or kidney failure
• Low red blood cell count (anemia)

Joe Lyon is a highly-rated personal injury and workplace exposure lawyer representing plaintiffs nationwide in a wide variety of toxic tort and asbestos injury claims.

Risk factors for occupational cancers include working near operations that use industrial chemicals. Worksites known to use cancer-causing toxins include:

• Farms
• Oil Refineries
• Nail Salons
• Fracking sites
• Paint manufacturers
• Construction sites
• Auto & Body shops
• Rail Yards

Toxins Associated with Multiple Myeloma

• Benzene
• Trichloroethylene (TCE)
• Vinyl Chloride (VC)
• Glyphosate
• Polycyclic aromatic hydrocarbons (PAHs)
• Polychlorinated biphenyls (PCBs)
• Chlorpyrifos
• Paraquat
• Tetrachlorethylene (PCE)
• Xylene
• Toluene
• Diesel Fumes

The Lyon Firm takes pride in representing plaintiffs and victims of toxic exposure. When a company produces a dangerous product or a company fails to protect their employees, legal action may be the only way to recover rightful compensation. Toxic exposure lawsuits can generate large settlements for injured plaintiffs.

Can I File a Multiple Myeloma Lawsuit?

Toxic exposure lawsuits involving multiple myeloma typically proceed under several legal theories, including negligence, strict liability, and failure to warn. Plaintiffs must establish that defendants knew or should have known about cancer risks associated with their products or operations, yet failed to implement adequate safety measures or provide proper warnings to exposed individuals.

Proving causation in multiple myeloma cases requires sophisticated medical and scientific evidence linking specific chemical exposures to cancer development. Expert testimony from oncologists, epidemiologists, and toxicologists becomes essential for demonstrating how particular substances contributed to disease onset. Latency periods between initial exposure and cancer diagnosis often span decades, making thorough documentation and reconstruction of exposure history critically important.

Statute of limitations considerations vary significantly across jurisdictions, with some states applying discovery rules that extend filing deadlines until patients reasonably could have connected their cancer to toxic exposure. Others maintain strict time limits from diagnosis or death, emphasizing the importance of prompt legal consultation following a multiple myeloma diagnosis.